Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. [electronic resource]
Producer: 20091103Description: 1753-63 p. digitalISSN:- 1522-9645
- Acute Coronary Syndrome -- drug therapy
- Adenosine Diphosphate -- metabolism
- Angioplasty, Balloon, Coronary -- methods
- Cell Adhesion Molecules -- metabolism
- Clopidogrel
- Female
- Humans
- Male
- Microfilament Proteins -- metabolism
- Middle Aged
- Myocardial Infarction -- drug therapy
- Phosphoproteins -- metabolism
- Phosphorylation
- Piperazines -- adverse effects
- Platelet Aggregation Inhibitors -- adverse effects
- Prasugrel Hydrochloride
- Thiophenes -- adverse effects
- Ticlopidine -- adverse effects
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.